Table 2 Qualitative sociodemographic, clinical, and laboratory characteristics and analysis of their association with the presence of Cyclospora spp. detected by Ziehl-Neelsen modified staining in stool samples of children and children with negative test results who consulted the emergency department of the Hospital San Juan De Dios De Armenia (Quindio, Colombia) between April and May 2022
Features | n/N (%) in children with positive tests versus children with negative tests for Cyclospora spp in feces | OR (CI95%) | p |
|---|---|---|---|
Social security regime: Contributory vs. subsidized | 7/15 (46,6%) vs. 65/135 (48,1%) | 0,9 (0,3 − 2,7) | 1,0 |
Male vs. Female Gender | 15/15 (100%) vs. 130/135 (96,3%) | Undefined | 1,0 |
Urban vs. Rural | 15/31 (48,3%) vs. 81/119 (68%) | 0,43 (0,1 − 0,9) | 0,057 |
Grade II or III dehydration at the time of consultation vs. no dehydration or grade I. | 5/15 (33,3%) vs. 49/135 (36,3%) | 0,8 (0,2–2,7) | 1,0 |
Abdominal pain | 6/15 (40%) vs. 49/135 (36,3%) | 1,1 (0,3–3,4) | 0,7 |
Fever | 14/15 (93,3%) vs. 79/135 (58,5%) | 9,9 (1,2–77,6) | 0,0096* |
Emesis | 5/15 (33,3%) vs. 74/135 (54,8%) | 0,4 (0,1–1,2) | 0,17 |
Hospitalized | 7/15 (46,6%) vs. 79/135 (58,5%) | 0,6 (0,2 − 1,8) | 0,41 |
Increased bacterial flora | 10/15 (66,6%) vs. 67/131 (51,1%) | 1,9 (0,6 − 5,8) | 0,28 |
Yeast | 5/14 (35,7%) vs. 34/105 (32,3%) | 1,1 (0,3–3,7) | 0,77 |
Mucus in stool | 6/15 (40%) vs. 54/133 (40,6%) | 0,9 (0,3 − 2,8) | 1,0 |
Blood in stool | 11/30 (36,6%) vs. 56/118 (47,4%) | 0,6 (0,2 − 1,4) | 0,31 |
Leukocytes in stool | 4/15 (26,6%) vs. 277,135 (20%) | 1,4 (0,4–4,9) | 0,51 |